RLAY vs RXRX
RLAY 与 RXRX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | RLAYRelay Therapeutics, Inc. | RXRXRECURSION PHARMACEUTICALS, INC. |
|---|---|---|
| 市值 | $3.81B | — |
| 市销率 | 248.4x | — |
| 营收同比增长 | 53.4% | 26.9% |
| 净利同比增长 | 18.1% | -39.1% |
| 息税前利润率 | -1971.6% | -867.9% |
| 净资产收益率 | -43.1% | -62.9% |
| 投入资本回报率 | — | -174.7% |
| 一年总回报 | +445.3% | -46.7% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:RLAY vs RXRX
| 指标 | RLAY | RXRX |
|---|---|---|
| 期末价值 | $6.1K | $941 |
| 总回报 | -38.9% | -90.6% |
| 年化收益 (CAGR) | -9.0% | -36.2% |
| 波动率 | 77.4% | 93.2% |
| 夏普比率 | 0.21 | -0.08 |
| 索提诺比率 | 0.32 | -0.13 |
| 最大回撤 | -94.7% | -93.1% |
基于 1319 个共同交易日,2021-04-16 → 2026-07-17 · 无风险利率 3.85%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)